A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV‐1 replication in cellular models

SY Gaikwad, S Tyagi, C Seniya, A More… - FEBS letters - Wiley Online Library
Nanotechnology offers promising avenues for enhancing drug delivery systems, particularly
in HIV‐1 treatment. This study investigates a nanoemulsified formulation combining …
相关文章

A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV-1 replication in cellular models

SY Gaikwad, S Tyagi, C Seniya, A More… - FEBS … - pubmed.ncbi.nlm.nih.gov
Nanotechnology offers promising avenues for enhancing drug delivery systems, particularly
in HIV-1 treatment. This study investigates a nanoemulsified formulation combining …

A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV-1 replication in cellular models.

SY Gaikwad, S Tyagi, C Seniya, A More… - FEBS …, 2024 - europepmc.org
Nanotechnology offers promising avenues for enhancing drug delivery systems, particularly
in HIV-1 treatment. This study investigates a nanoemulsified formulation combining …